Abstract
Background: Isocitrate dehydrogenase wild-type (WT) glioblastoma (GBM) accounts for 90% of all GBMs, yet only 27% of isocitrate dehydrogenase WT-GBMs ......
小提示:本篇文献需要登录阅读全文,点击跳转登录